28 January 2026 in Nature
Deep learning models that predict functional genomic measurements from DNA sequences are powerful tools for deciphering the genetic regulatory code. Existing methods involve a trade-off between input sequence length and prediction resolution, thereby limiting their modality scope and performance 1–5 . We present AlphaGenome, a unified DNA sequence model, which takes as input 1 Mb of DNA sequence and predicts thousands of functional genomic tracks up to single-base-pair resolution across diverse modalities. The modalities include gene expression, transcription initiation, chromatin accessibility, histone modifications, transcription factor binding, chromatin contact maps, splice site usage and splice junction coordinates and strength. Trained on human and mouse genomes, AlphaGenome matches or exceeds the strongest available external models in 25 of 26 evaluations of variant effect prediction. The ability of AlphaGenome to simultaneously score variant effects across all modalities accurately recapitulates the mechanisms of clinically relevant variants near the TAL1 oncogene 6 . To facilitate broader use, we provide tools for making genome track and variant effect predictions from sequence.
20 September 2026 in medRxiv
A major challenge in genomics is deciphering the functional consequences of non-coding genetic variation. Here we present AlphaGenome Atlas, a comprehensive resource that enables the joint interpretation and prioritization of variant effects across the entire human genome. Using AlphaGenome, we predicted the regulatory effects across thousands of molecular phenotypes for every possible human single nucleotide variant and many observed indels. These predictions were then used to derive a unified and interpretable AlphaGenome Variant Impact (AVI) score and to map cis-regulatory motifs across the genome. AVI achieved state-of-the-art performance across diverse benchmarks with improved prioritization of deleterious non-coding variants. Application of the combined Atlas resource helped solve an epileptic encephalopathy rare disease case, increased the statistical power to detect rare non-coding variants driving population-level phenotypes, and enhanced the mechanistic interpretation of these variants. Thus, AlphaGenome Atlas improves the prioritization and molecular interpretation of non-coding variants with genetic and clinical significance.
17 November 2026 in bioRxiv
Most genetic variants associated with human traits and diseases lie in non-coding DNA, where they can alter gene regulation in specific cell types and states. Single-cell atlases chart these states across tissues and development, but rarely profile enough donors to associate variants with expression directly. Deep learning models could bridge this gap by predicting variant effects from DNA sequence, yet they poorly distinguish related cell states and require fine-tuning for new datasets. Here we present AlphaGenome 2 (AG2), which substantially advances cell-type-specific prediction of regulatory activity and variant effects for gene expression and chromatin accessibility. Trained on organism-wide human and mouse single-cell atlases and bulk functional genomics data, AG2 takes as input a 1-Mb DNA sequence and a condition specifying a target tissue, cell type, or cell state. Conditioning enables AG2 to impute unmeasured epigenomic tracks and predict multimodal variant effects across cell types. Inferring this condition directly from gene expression extends AG2 to unseen datasets and cell states without fine-tuning. AG2 outperforms fine-tuned AlphaGenome 1 and specialized models trained on target datasets, doubling recall of causal single-cell eQTLs at 90% precision. AG2 also achieves state-of-the-art enhancer-gene linking and can pinpoint causal variants at complex trait loci. Across hundreds of human cell types, we generated an atlas of enhancer-gene links and scores for 7 million common variants. As single-cell profiling expands across development, tissues, and disease cohorts, AG2 provides a blueprint for turning observational atlases into variant effect maps.